Cargando…
Identifying responders to elamipretide in Barth syndrome: Hierarchical clustering for time series data
BACKGROUND: Barth syndrome (BTHS) is a rare genetic disease that is characterized by cardiomyopathy, skeletal myopathy, neutropenia, and growth abnormalities and often leads to death in childhood. Recently, elamipretide has been tested as a potential first disease-modifying drug. This study aimed to...
Autores principales: | Van den Eynde, Jef, Chinni, Bhargava, Vernon, Hilary, Thompson, W. Reid, Hornby, Brittany, Kutty, Shelby, Manlhiot, Cedric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088720/ https://www.ncbi.nlm.nih.gov/pubmed/37041653 http://dx.doi.org/10.1186/s13023-023-02676-8 |
Ejemplares similares
-
Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome
por: Hornby, Brittany, et al.
Publicado: (2022) -
A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism
por: Reid Thompson, W., et al.
Publicado: (2020) -
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide
por: Sabbah, Hani N.
Publicado: (2020) -
Data Quality Degradation on Prediction Models Generated From Continuous Activity and Heart Rate Monitoring: Exploratory Analysis Using Simulation
por: Hearn, Jason, et al.
Publicado: (2023) -
Quality of life in Barth syndrome
por: Kim, Alexander Y., et al.
Publicado: (2022)